Douglas Jorenby

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi request reprint Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial
    Douglas E Jorenby
    University of Wisconsin School of Medicine and Public Health, Center for Tobacco Research and Intervention, Madison, Wis 53711, USA
    JAMA 296:56-63. 2006
  2. ncbi request reprint Clinical efficacy of bupropion in the management of smoking cessation
    Douglas Jorenby
    Department of Medicine, Center for Tobacco Research and Intervention, University of Wisconsin Medical School, 1930 Monroe Street, Madison, WI 53711, USA
    Drugs 62:25-35. 2002
  3. pmc Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment
    Megan E Piper
    Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, Madison, WI 53711, USA
    Addiction 106:418-27. 2011
  4. ncbi request reprint Smoking cessation via the internet: a randomized clinical trial of an internet intervention as adjuvant treatment in a smoking cessation intervention
    Sandra J Japuntich
    Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, 1930 Monroe Street, Suite 200, Madison, WI 53711, USA
    Nicotine Tob Res 8:S59-67. 2006
  5. ncbi request reprint Depression predicts smoking early but not late in a quit attempt
    Sandra J Japuntich
    Psychology Department, Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
    Nicotine Tob Res 9:677-86. 2007
  6. pmc Smoking, barriers to quitting, and smoking-related knowledge, attitudes, and patient practices among male physicians in China
    Marion Ceraso
    University of Wisconsin School of Medicine and Public Health, 387 WARF Bldg, 610 Walnut St, Madison, WI 53726, USA
    Prev Chronic Dis 6:A06. 2009
  7. pmc A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies
    Megan E Piper
    Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, Madison, WI 53711, USA
    Arch Gen Psychiatry 66:1253-62. 2009
  8. pmc Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics
    Stevens S Smith
    Department of Medicine and Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, Madison, 53711, USA
    Arch Intern Med 169:2148-55. 2009
  9. pmc Prerelease intent predicts smoking behavior postrelease following a prison smoking ban
    Laura Thibodeau
    Department of Medicine, Section of General Internal Medicine, University of Wisconsin Hospital and Clinics, School of Medicine and Public Health, Madison, WI, USA
    Nicotine Tob Res 12:152-8. 2010
  10. pmc Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials
    Megan E Piper
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Center for Tobacco Research and Intervention, Madison, WI 53711, USA
    Nicotine Tob Res 12:647-57. 2010

Detail Information

Publications25

  1. ncbi request reprint Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial
    Douglas E Jorenby
    University of Wisconsin School of Medicine and Public Health, Center for Tobacco Research and Intervention, Madison, Wis 53711, USA
    JAMA 296:56-63. 2006
    ..Varenicline, a partial agonist at the alpha4beta2 nicotinic acetylcholine receptor, has the potential to aid smoking cessation by relieving nicotine withdrawal symptoms and reducing the rewarding properties of nicotine...
  2. ncbi request reprint Clinical efficacy of bupropion in the management of smoking cessation
    Douglas Jorenby
    Department of Medicine, Center for Tobacco Research and Intervention, University of Wisconsin Medical School, 1930 Monroe Street, Madison, WI 53711, USA
    Drugs 62:25-35. 2002
    ....
  3. pmc Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment
    Megan E Piper
    Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, Madison, WI 53711, USA
    Addiction 106:418-27. 2011
    ..To understand the relations among anxiety disorders and tobacco dependence, withdrawal symptoms, response to smoking cessation pharmacotherapy and ability to quit smoking...
  4. ncbi request reprint Smoking cessation via the internet: a randomized clinical trial of an internet intervention as adjuvant treatment in a smoking cessation intervention
    Sandra J Japuntich
    Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, 1930 Monroe Street, Suite 200, Madison, WI 53711, USA
    Nicotine Tob Res 8:S59-67. 2006
    ..05). In sum, results suggest that participants used CHESS SCRP frequently, CHESS SCRP use was related to success, but the effects in general did not yield intergroup effects...
  5. ncbi request reprint Depression predicts smoking early but not late in a quit attempt
    Sandra J Japuntich
    Psychology Department, Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA
    Nicotine Tob Res 9:677-86. 2007
    ..Prediction models including depression history and depression-related measures (e.g., negative affect, negative cognitive style) showed that depression history was a powerful predictor of smoking early in the quit attempt...
  6. pmc Smoking, barriers to quitting, and smoking-related knowledge, attitudes, and patient practices among male physicians in China
    Marion Ceraso
    University of Wisconsin School of Medicine and Public Health, 387 WARF Bldg, 610 Walnut St, Madison, WI 53726, USA
    Prev Chronic Dis 6:A06. 2009
    ....
  7. pmc A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies
    Megan E Piper
    Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, Madison, WI 53711, USA
    Arch Gen Psychiatry 66:1253-62. 2009
    ..Little direct evidence exists on the relative efficacies of different smoking cessation pharmacotherapies, yet such evidence is needed to make informed decisions about their clinical use...
  8. pmc Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics
    Stevens S Smith
    Department of Medicine and Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, Madison, 53711, USA
    Arch Intern Med 169:2148-55. 2009
    ..Effectiveness trials (eg, in primary care settings) are needed to estimate the benefits of cessation treatments in real-world use...
  9. pmc Prerelease intent predicts smoking behavior postrelease following a prison smoking ban
    Laura Thibodeau
    Department of Medicine, Section of General Internal Medicine, University of Wisconsin Hospital and Clinics, School of Medicine and Public Health, Madison, WI, USA
    Nicotine Tob Res 12:152-8. 2010
    ..The Wisconsin Department of Corrections smoking ban is a unique opportunity to investigate determinants of smoking behavior after release from prison...
  10. pmc Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials
    Megan E Piper
    Department of Medicine, University of Wisconsin School of Medicine and Public Health, Center for Tobacco Research and Intervention, Madison, WI 53711, USA
    Nicotine Tob Res 12:647-57. 2010
    ..Women, Blacks, and people with low socioeconomic status are especially vulnerable to the health risks of smoking and are less likely to quit...
  11. ncbi request reprint Integrating smoking cessation treatment into primary care: an effectiveness study
    Michael C Fiore
    Department of Medicine, University of Wisconsin Medical School, Milwaukee, WI 53233, USA
    Prev Med 38:412-20. 2004
    ..This study assessed acceptability, utilization, and effectiveness of free smoking cessation treatment among diverse primary care patients...
  12. ncbi request reprint Use of the vital sign stamp as a systematic screening tool to promote smoking cessation
    Megan E Piper
    Wisconsin Medical School Center for Tobacco Research and Intervention, University of Wisconsin Medical School, Madison 53711 2027, USA
    Mayo Clin Proc 78:716-22. 2003
    ..To examine the ability of a simple system-wide screening assessment tool, an expanded vital sign stamp, to increase rates of smoker identification, physician advice to quit smoking, and physician assistance in quitting and abstinence rates...
  13. ncbi request reprint Targeting smokers at increased risk for relapse: treating women and those with a history of depression
    Stevens S Smith
    Center for Tobacco Research and Intervention, Department of Medicine, University of Wisconsin Medical School, Madison, Wisconsin 53711 2027, USA
    Nicotine Tob Res 5:99-109. 2003
    ..We conclude that bupropion SR is a first-line treatment for smoking that has the potential to benefit all smokers, especially women and the previously depressed...
  14. pmc A comparison of the nicotine lozenge and nicotine gum: an effectiveness randomized controlled trial
    Quinn R Pack
    Department of Medicine, University of Wisconsin, Madison, WI, USA
    WMJ 107:237-43. 2008
    ..Seven-day point prevalence of smoking abstinence was biochemically confirmed by exhaled carbon monoxide levels of less than 10 ppm measured at 8 weeks with follow-up at 6 and 12 months...
  15. ncbi request reprint Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation
    Jane E Anderson
    Center for Tobacco Research and Intervention, University of Wisconsin Medical School, Madison, WI 53711 2027, USA
    Chest 121:932-41. 2002
    ..By becoming fluent in the clinical interventions and by implementing the simple institutional changes described in this article and in the guideline, chest clinicians can more effectively intervene with their patients who smoke...
  16. ncbi request reprint Smoking cessation, but not smoking reduction, reduces plasma homocysteine levels
    James H Stein
    Center for Tobacco Research and Intervention, Department of Medicine, University of Wisconsin Medical School, Madison, USA
    Clin Cardiol 25:23-6. 2002
    ..Although hyperhomocysteinemia may mediate some of the adverse cardiovascular consequences of smoking cigarettes, the effects of smoking cessation and smoking reduction on homocysteine levels have not been evaluated previously...
  17. doi request reprint A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling
    Danielle E McCarthy
    Department of Psychology, Rutgers University, Piscataway, NJ 08854, USA
    Nicotine Tob Res 10:717-29. 2008
    ..17, 95% CI 0.68-2.03) or prolonged abstinence (OR = 1.26, 95% CI 0.75-2.12) substantially when offered in conjunction with active medication...
  18. ncbi request reprint The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial
    Raymond Niaura
    Brown University, Providence, RI, USA
    Curr Med Res Opin 24:1931-41. 2008
    ..To determine whether self-regulated flexible dosing with varenicline tartrate is safe and effective for smoking cessation...
  19. ncbi request reprint Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations
    Thomas M Piasecki
    Department of Psychological Sciences, University of Missouri Columbia 65211, USA
    J Abnorm Psychol 112:14-27. 2003
    ..The findings complement earlier heterogeneity studies in implicating the pattern of changing withdrawal symptoms over time as a factor strongly associated with smoking relapse...
  20. ncbi request reprint Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers
    Thomas M Piasecki
    Department of Psychological Sciences, University of Missouri Columbia 65211, USA
    J Abnorm Psychol 112:3-13. 2003
    ..These results reinforce the conclusion that withdrawal symptoms are highly variable and argue against discarding withdrawal data from participants who lapse...
  21. ncbi request reprint Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving
    Saul Shiffman
    Pinney Associates and the University of Pittsburgh, 201 North Craig Street, Suite 320, Pittsburgh, PA 15213, USA
    Psychopharmacology (Berl) 166:343-50. 2003
    ..Acute cravings, often provoked by exposure to smoking cues, appear to be important triggers for smoking relapse. Relief of acute craving may therefore be an important step in preventing relapse...
  22. ncbi request reprint Impact of prior nicotine replacement therapy on smoking cessation efficacy
    Michael J Durcan
    GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Am J Health Behav 26:213-20. 2002
    ..To examine previous use of nicotine replacement therapy (NRT) on the smoking-cessation efficacy of bupropion sustained release (SR)...
  23. ncbi request reprint Comment: Oral varenicline for smoking cessation
    David Gonzales
    Ann Pharmacother 41:720-1. 2007
  24. ncbi request reprint Predicting relapse back to smoking: contrasting affective and physical models of dependence
    Susan L Kenford
    Department of Psychology, Xavier University, Cincinnati, Ohio 45207 6511, USA
    J Consult Clin Psychol 70:216-27. 2002
    ..Affective reactivity appears to be a core constituent of dependence...
  25. ncbi request reprint Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity
    Thomas M Piasecki
    Department of Psychological Sciences, University of Missouri Columbia, Columbia, MO 65211, USA
    Exp Clin Psychopharmacol 11:276-85. 2003
    ..Prior research has shown that these symptom facets predict later relapse: thus, current pharmacotherapies may aid cessation by diminishing withdrawal severity, but they do not affect all clinically important aspects of withdrawal...